top of page

Technotes, Publications, Technology platforms and FAQs


Publications and Technotes

ACS Biomarker aims to advance translational research by publishing high-quality data in peer reviewed journals. See our technotes for details on our measurement and analysis pipeline.



Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients.

Bayés-Genis A. et al. Eur J Heart Fail. 2017 Sep 26


Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure.

van Boven N. et al. Eur J Heart Fail. 2017 Sep 26

Circulating miRNA Analysis Guidelines

De Ronde et al. RNA. 2017 May;23(5):811-821

miR-22-3p in heart failure

Van Boven et al. Int J Cardiol. 2017 May 15;235:124-132

MiR423-5p as a circulating biomarker for heart failure.

Tijsen et al. Circ Res. 2010 Apr 2;106(6):1035-9. 

Exosome Extractions

Sample submission

Sample preparation


Cardio-Onco Biomarker Panel

miRNA profiling


RNA profiling platform

To obtain high quality results we have chosen the superior miRNA platform of Quantabio for our biomarker services. This platform offers a cost-effective method to measure multiple RNA molecules from a single RT reaction. The open technology provides flexibility to design your own assay primers and eliminates inefficient stem-loop priming and costly hydrolysis probes. It has been reported as one of the best miRNA profiling platforms and guarantees to deliver reliable results.

Tech platforms
bottom of page